DEVELOPMENT OF MILK-TARGETED TRANSGENIC ANIMALS EXPRESS-ING COAGULATION FACTOR VIII BIOENGINEERED FOR HIGH EFFI-CIENCY SECRETION
HZ Miao 1 , ST Butler 2 , WH Velander 3 , and SW Pipe 1 , Virginia Tech 2 , Blacksburg, VA, University of Nebraska 3 , Lincoln, NE and University of Michigan 1 , Ann Arbor, MI. The lifelong hemorrhagic diathesis of hemophilia A is treated successfully with recombinantly derived factor VIII (rFVIII). rFVIII is presently produced and purified from mammalian cell lines in liquid culture but has proven to be costly. The milk of transgenic livestock can yield an abundant source of complex therapeutic proteins such as recombinant coagulation proteins. Only the pig mammary gland has been shown to carry out all of the post-translational modifications necessary to generate the biological activity and long circulation half-life needed for complex glycoproteins. Velander and colleagues have demonstrated that human recombinant factor IX can be produced at levels up to 100 U/ml. However, yields of rFVIII have been much lower and subject to chain dissociation due to the harsh chelating environment and/or the absence of vWF. Through bioengineering strategies we have developed rFVIII variants with enhanced secretion (F309S/226aa/N6) and stability (IR8). Our goal is to express these rFVIII variants (F309S/226/N6 and IR8) in the milk of transgenic mice and pigs under the murine Whey Acidic Milk Protein (WAP) promoter and downstream 3' UTR elements. Transgenic mice provide both insight into the encoding fidelity of the transgene constructions as generally expressed by mammary epithelia but also provide useful amounts (ie. Ͼ1 ml per lactation at Ͼ20 ug/ml) of post-translationally modified, recombinant protein for evaluation. We have created 6 murine transgenic lineages that express the rFVIII variants either alone or in combination with vWF and/or alpha1-antitrypsin. We are co-expressing these constructions with vWF to help stabilize the rFVIII variants. We have expressed vWF previously in the milk of transgenic mice at greater than 100 ug/ml. We are also co-expressing alpha1-antitrypsin as this has been shown to dramatically reduce the amount of proteolytic degradation in milk. Trigenic and bigenic combinations of these constructs were mixed equal molar and microinjected into mouse zygotes to produce transgenic mice at the University of Michigan. Founder animal lineages are presently being outbred with wild-type mice. The resulting F1 lineages will undergo induced lactation and the milk analyzed for rFVIII content. Trigenic, transgenic pig fibroblast lines have also been made and lineages are awaiting nuclear transfer in August 2006. Epigenetic regulation refers to changes in gene expression that occur without changes in the nucleotide sequence. Cytosine methylation and histone tail modifications are two epigenetic modifications that influence gene expression. Elucidating epigenetic mechanisms of gene regulation is becoming increasingly important as deregulation of epigenetic processes is observed in many diseases, including cancer. The CXXC1 gene encodes CXXC finger protein 1 (CFP1), a transcriptional activator that specifically binds unmethylated CpG dinucleotides. The specific binding activity of CFP1 makes it unique in that most CpG binding proteins bind methylated CpG dinucleotides and facilitate heterochromatin formation. CFP1 has recently been identified as a member of the mammalian SET1 histone H3 lysine 4 methyltransferase complex. Disruption of CXXC1 in mice results in an early embryonic lethal phenotype, therefore CXXC1-/-embryonic stem (ES) cells were isolated from CXXC1-/-blastocysts to further characterize the function of CFP1. Embryonic stem cells lacking expression of CFP1 exhibit multiple epigenetic modification defects including altered histone modifications and reduced global cytosine methylation. DNA methyltransferase 1 (Dnmt1) is the major source of DNA methyltransferase activity in mammalian cells and is responsible for copying methylation patterns during DNA replication. Dnmt1 protein level and methyltransferase activity are decreased by ϳ50% in CXXC1-/-ES cells and are rescued by stable expression of murine CFP1. Dnmt1 transcript level is not reduced in CXXC1 -/-ES cells, however. Immunoprecipitation experiments revealed an interaction between CFP1 and Dnmt1 in vivo. Regulation of Dnmt1 protein level and activity by CFP1 is an exciting discovery in that it is the first example of reduced Dnmt1 protein without direct disruption of Dnmt1 gene function. The functional significance of this novel intersection of epigenetic regulatory proteins is the principle focus of ongoing experiments. The relationship between fetal cardiomyocyte growth and in vivo phosphorylation and activation of the three arms of the MAPK cascade (ERK, p38 and JNK) is only beginning to be understood. Because we know that phosphorylation of ERK is necessary for fetal sheep cardiomyocyte proliferation and enlargement in vitro, and p38 phosphorylation has been described in pressure-loaded fetal sheep hearts in vivo, we hypothesized that ERK and p38 phosphorylated would be increased in the hearts of fetal sheep with chronic arterial and venous hypertension. Methods: Fetal sheep were instrumented with intravascular catheters to permit arterial and venous access for pressure measurements, sampling and infusions. Following recovery, fetuses were infused with plasma protein (ϳ13g/day) for 8Ϯ1 days, which we have previously shown to gradually increase arterial and venous pressures. At the conclusion of the experiment (138Ϯ1 days of 145 day gestation), fetal body, heart and ventricular freewall weights were measured, and freewalls were frozen in liquid nitrogen. Age-matched fetuses served as controls. Levels of protein expression and phosphorylation were measured by Western blot analysis in right ventricular (RV) extracts (ERK phosphorylation was also measured in left ventricles [LV] ). Data were normalized as phosphorylated-to-total protein. Groups were compared by t-tests (data shown as mean ϮSD). Results: Chronic intravascular infusion of plasma increased fetal arterial and venous pressures by 50% and 60%, respectively (8Ϯ1 days compared to baseline). Heart weight was greater in hypertensive fetuses than control fetuses (37Ϯ4 vs. 27Ϯ7g), but body weights were not different. ERK phosphorylation was 300-400% greater in the ventricles of hypertensive fetuses than control fetuses (LV pϾ0.01; RV pϾ0.04). Although mean p38 phosphorylation was 385% greater in the RVs of hypertensive fetuses than control fetuses, this result did not reach statistical significance (pϭ0.07); phosphorylation of p38 occurred very strongly in some RVs but less in others. Phosphorylation of JNK was not different between hypertensive and control fetuses. Discussion: In this model, onset of arterial and venous hypertension is gradual, thus chronic rather than acute activation of ERK (and perhaps p38) may be the most significant signals regulating cardiomyocyte proliferation, enlargement or terminal differentiation previously shown to be occurring in these fetal hearts.
CARDIAC ERK ACTIVATION DURING SUSTAINED ARTERIAL AND VE-NOUS HYPERTENSION IN THE SHEEP FETUS.
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ORAL FEEDING DISORDERS AT HOSPITAL DISCHARGE: A UNIQUE MARKER OF DISABILITY?
SB Allen, University of Kansas Medical Center, Kansas City, KS, and CA Castor, CA Lambrecht, and HW Kilbride, Children's Mercy Hospitals & Clinics, Kansas City, MO.
The purpose of this study was to determine the prevalence of oral feeding problems at hospital discharge for preterm infants and to assess if these could be markers of later disability. This was a retrospective review of patients enrolled in a follow-up clinic database. Infants included were Յ 32 wk GA, seen for the initial clinic visit between January 1, 2002 to December 31, 2004. 71/328 (22%) infants had oral feeding disorders (OFD) as defined by having one or more of the following at hospital dismissal: use of tubes and/or feeding pump, feeding more frequently than every 3 hours secondary to poor volume tolerance, and/or less than 100% of feeding orally. A comparison group of infants was determined by matching each study infant with the next infant in the database without a feeding problem but with the same GA (Ϯ 1 wk) and BW (Ϯ 100g). Medical complications and limited outcome data were obtained by database review. Group differences were determined by chi-square and univariate analysis of variance with significance indicated by PϽ.05.
There were no group differences in BW (1023 Ϯ 370 and 1026 Ϯ 345 g, OFD and control, respectively), GA (27.6 Ϯ 2.5 wk, both), or gender. OFD infants were, on average, discharged from the hospital 5 weeks later and 880 g heavier than comparisons (Pϭ.000). There were no group differences in rates of severe IVH or ROP. OFD infants were more likely to have CLD (52% and 35%, Pϭ.04) and be discharged on a home apnea monitor (47% and 25%, Pϭ.009). 39% of OFD infants had neither CLD or IVH. A subset of infants had 24-month developmental screening using the Bayley Infant Neurodevelopmental Screener (BINS). Controlling for CLD and maternal race, OFD infants (nϭ14) tended to have a lower mean BINS scores than comparisons (nϭ30), 6.9 Ϯ 3.6 and 4.3 Ϯ 3.2, Pϭ.08.
Preterm infants appear to frequently have oral feeding problems at hospital discharge. Additional study of this population is needed to determine possible etiologies and long-term implications of delayed oral feeding, which could be a unique marker of disability. Endothelial progenitors play an important role in both postnatal vasculogenesis and vascular homeostasis. Based on proliferative potential, we have recently identified a hierarchy of endothelial colony forming cells (ECFCs) in human blood and blood vessels. We questioned whether the hierarchy of ECFCs also existed in the swine and whether a cardiovascular stress would affect this hierarchy. Therefore, we investigated the distribution of ECFCs by a single cell endothelial colony forming assay in normal pigs and pigs following acute myocardial ischemia (AMI) (nϭ5) or placement of a coronary stent (nϭ3). In normal animals, the hierarchy of ECFCs was present in circulating blood and aortic endothelium. In experimental pigs with AMI, the percent of single cells derived from peripheral blood that formed colonies doubled after 45 minutes of AMI. Moreover, the percent of high proliferative potential ECFC (HPP-ECFC) (Ͼ2000 cells/colony) was significantly increased by16-fold after 45 minutes of AMI compared to baseline (2.5%) and 2-fold higher than the frequency measured from the samples obtained at sacrifice 7 days later (14%). On the other hand, the percent of endothelial cluster (2-50 cells/colony) was reduced more than 3 fold following 45 minutes of AMI. The percent of HPP-ECFC from aortic endothelium in the stented pigs was 3-fold higher than that observed in the control pigs. Likewise, HPP-ECFCs were present in peripheral blood samples taken from stented pigs but were not detectable in the control pigs. These experimental animal observations (1) indicated that ECFCs circulate in the blood and are present in vascular intima in the normal swine and (2) revealed that the distribution of ECFCs in the vascular endothelium and circulation are altered during the early events of cardiovascular injury. Further studies will be required to determine whether the change of ECFCs distribution is resulting from the mobilization of endothelial progenitors from bone marrow or from vascular endothelial intima.
ALTERATION OF THE DISTRIBUTION OF ENDOTHELIAL COLONY FORM-ING CELLS (ECFCS) IN SWINE MODELS OF CARDIOVASCULAR INJURY.
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